
Sideline Gold on Fe...


| PCR | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 48.40 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 34.79 | -47.76 | -20.82 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 22.30 | 2.27 | 0.48 |
| Net Income | -100.00 | -19.56 | 0.00 |
| EPS | -100.00 | -11.43 | 0.00 |
| EBITDA | 226.83M |
| REVENUE | 5.66B |
| Qtr (06/09) | Qtr (09/09) | FY (12/09) | FY (12/10) | |
|---|---|---|---|---|
| Average Estimate | $0.71 | $0.67 | $2.78 | $2.70 |
| Number of Analysts | 3 | 3 | 4 | 3 |
| High Estimate | $0.72 | $0.69 | $2.80 | $2.75 |
| Low Estimate | $0.70 | $0.65 | $2.75 | $2.60 |
| Prior Year | $1.03 | $1.01 | $3.67 | $2.78 |
| Growth Rate (Year over Year) | -31.07% | -33.33% | -24.39% | -2.70% |